Keras Resources plc ('Keras' or 'the Company')
Holdings in the Company
Keras announces that it was notified on 13 March 2023 by AxCap Ventures Inc ("Axcap") that Axcap have sold their entire holding of 5,610,000 ordinary shares of 1 pence each in the Company and no longer hold a notifiable interest in the Company's issued share capital.
Other than as previously announced by RNS, Keras has no further information pursuant to Rule 17 Schedule Five of the AIM Rules for Companies in respect of any dealings by AxCap Ventures Inc in the Ordinary Share capital of the Company.
For further information please visit www.kerasplc.com, follow us on Twitter @kerasplc or contact the following:
Graham Stacey Annabel Redford | Keras Resources plc | annabel@kerasplc.com
|
Nominated Adviser & Joint Broker Ewan Leggat / Charlie Bouverat
Joint Broker Damon Heath / Erik Woolgar
Financial and Corporate Communications Felicity Winkles
| SP Angel Corporate Finance LLP
Shard Capital Partners LLP
Celicourt | +44 (0) 20 3470 0470
+44 (0) 207 186 9900
+44 (0) 774 884 3871 |
Notes:
Keras Resources (AIM: KRS) wholly owns the Diamond Creek organic phosphate mine in Utah, US. Diamond Creek is one of the highest-grade organic phosphate deposits in the US and is a fully integrated mine to market operation with in-house processing facilities. The operation produces a variety of organic phosphate products that can be tailored to customer requirements for fertiliser.
The Company is focused on continuing to build market share in the fast-growing US organic fertiliser market and build Diamond Creek into the premier organic phosphate producer in the US.
Additionally, Keras holds an 85% interest in the Nayéga manganese project in Togo, which hosts an 8.4 million tonne manganese oxide Ore Reserve in northern Togo, held through Togolese subsidiary Société Générale des Mines SA (SGM).
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.